151 related articles for article (PubMed ID: 38749063)
21. A Protocol for a Pan-Canadian Prospective Observational Study on Active Surveillance or Surgery for Very Low Risk Papillary Thyroid Cancer.
Sawka AM; Ghai S; Tomlinson G; Baxter NN; Corsten M; Imran SA; Bissada E; Lebouef R; Audet N; Brassard M; Zhang H; Gupta M; Nichols AC; Morrison D; Johnson-Obeski S; Prisman E; Anderson D; Chandarana SP; Ghaznavi S; Jones J; Gafni A; Matelski JJ; Xu W; Goldstein DP;
Front Endocrinol (Lausanne); 2021; 12():686996. PubMed ID: 34194396
[TBL] [Abstract][Full Text] [Related]
22. Active Surveillance for T1bN0M0 Papillary Thyroid Carcinoma.
Sakai T; Sugitani I; Ebina A; Fukuoka O; Toda K; Mitani H; Yamada K
Thyroid; 2019 Jan; 29(1):59-63. PubMed ID: 30560718
[TBL] [Abstract][Full Text] [Related]
23. Ablation techniques or active surveillance compared to surgical resection in patients with low-risk papillary thyroid cancer: a systematic review and meta-analysis.
Ledesma-Leon T; Solis-Pazmino P; Lincango EP; Figueroa LA; Ellenhorn J; Nasseri Y; Cohen J; Romero-Arenas M; Garcia C; Sanabria A; Rojas T; Torres-Román J; Camacho E; Vallejo S; Alvarado-Mafla B; Dream S; James BC; Ponce OJ; Sharma A; Brito JP
Endocrine; 2024 Feb; 83(2):330-341. PubMed ID: 37658978
[TBL] [Abstract][Full Text] [Related]
24. Active Surveillance for Low-Risk Differentiated Thyroid Cancer.
Ahmadi S; Alexander EK
Endocr Pract; 2023 Feb; 29(2):148-153. PubMed ID: 36270610
[TBL] [Abstract][Full Text] [Related]
25. Active surveillance of low-risk papillary thyroid cancer: A meta-analysis.
Saravana-Bawan B; Bajwa A; Paterson J; McMullen T
Surgery; 2020 Jan; 167(1):46-55. PubMed ID: 31526581
[TBL] [Abstract][Full Text] [Related]
26. Surgery alone for papillary thyroid microcarcinoma is less costly and more effective than long term active surveillance.
Lin JF; Jonker PKC; Cunich M; Sidhu SB; Delbridge LW; Glover AR; Learoyd DL; Aniss A; Kruijff S; Sywak MS
Surgery; 2020 Jan; 167(1):110-116. PubMed ID: 31543327
[TBL] [Abstract][Full Text] [Related]
27. Management of Low-Risk Thyroid Cancers: Is Active Surveillance a Valid Option? A Systematic Review of the Literature.
Patrone R; Velotti N; Masone S; Conzo A; Flagiello L; Cacciatore C; Filardo M; Granata V; Izzo F; Testa D; Avenia S; Sanguinetti A; Polistena A; Conzo G
J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34441866
[TBL] [Abstract][Full Text] [Related]
28. Insights into the Management of Papillary Microcarcinoma of the Thyroid.
Miyauchi A; Ito Y; Oda H
Thyroid; 2018 Jan; 28(1):23-31. PubMed ID: 28629253
[TBL] [Abstract][Full Text] [Related]
29. Active surveillance for PTMC warranted for the UK population?
Maniam P; Harding N; Li L; Adamson R; Hay A; Nixon I
Clin Otolaryngol; 2023 Jan; 48(1):88-93. PubMed ID: 36183341
[TBL] [Abstract][Full Text] [Related]
30. Conservative management of low-risk papillary thyroid carcinoma: a review of the active surveillance experience.
Smulever A; Pitoia F
Thyroid Res; 2023 Mar; 16(1):6. PubMed ID: 36907911
[TBL] [Abstract][Full Text] [Related]
31. Active Surveillance of Thyroid Microcarcinomas: a Critical View.
Cernea CR; Matos LL; Eugênio C; Ferreira GM; Cerqueira YS; Leite AKN; Vanderlei FAB; de Carlucci D; Gotoda RN; Hojaij FC; Araújo-Filho VJF
Curr Oncol Rep; 2022 Jan; 24(1):69-76. PubMed ID: 35061193
[TBL] [Abstract][Full Text] [Related]
32. Experience with Active Surveillance of Thyroid Low-Risk Carcinoma in a Developing Country.
Sanabria A
Thyroid; 2020 Jul; 30(7):985-991. PubMed ID: 31950887
[No Abstract] [Full Text] [Related]
33. Thyroid Cancer Active Surveillance Program Retention and Adherence in Japan.
Davies L; Chang CH; Sirovich B; Tuttle RM; Fukushima M; Ito Y; Miyauchi A
JAMA Otolaryngol Head Neck Surg; 2021 Jan; 147(1):77-84. PubMed ID: 33237264
[TBL] [Abstract][Full Text] [Related]
34. Thyroid FNA cytology in Asian practice-Active surveillance for indeterminate thyroid nodules reduces overtreatment of thyroid carcinomas.
Kakudo K; Higuchi M; Hirokawa M; Satoh S; Jung CK; Bychkov A
Cytopathology; 2017 Dec; 28(6):455-466. PubMed ID: 29094782
[TBL] [Abstract][Full Text] [Related]
35. Thyroid Cancer Treatment Choice: A Pilot Study of a Tool to Facilitate Conversations with Patients with Papillary Microcarcinomas Considering Treatment Options.
Brito JP; Moon JH; Zeuren R; Kong SH; Kim YG; Iñiguez-Ariza NM; Choi JY; Lee KE; Kim JH; Hargraves I; Bernet V; Montori VM; Park YJ; Tuttle RM
Thyroid; 2018 Oct; 28(10):1325-1331. PubMed ID: 29905089
[TBL] [Abstract][Full Text] [Related]
36. Active Surveillance May Be the Best Initial Management for Papillary Thyroid Microcarcinoma.
Ito Y; Miyauchi A
J Endocr Soc; 2023 Jun; 7(7):bvad063. PubMed ID: 37287648
[TBL] [Abstract][Full Text] [Related]
37. Age-stratified comparison of active surveillance versus radiofrequency ablation for papillary thyroid microcarcinoma using decision analysis.
Carlisle KM; Brown JP; Kim J; Turner DJ; Slejko JF; Kuo JH; Mullins CD; Hu Y
Surgery; 2024 Jan; 175(1):153-160. PubMed ID: 37872047
[TBL] [Abstract][Full Text] [Related]
38. Papillary Thyroid Microcarcinoma: Active Surveillance Against Surgery. Considerations of an Italian Working Group From a Systematic Review.
Orlando G; Scerrino G; Corigliano A; Vitale I; Tutino R; Radellini S; Cupido F; Graceffa G; Cocorullo G; Salamone G; Melfa G
Front Oncol; 2022; 12():859461. PubMed ID: 35402255
[TBL] [Abstract][Full Text] [Related]
39. A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary Microcarcinoma.
Brito JP; Ito Y; Miyauchi A; Tuttle RM
Thyroid; 2016 Jan; 26(1):144-9. PubMed ID: 26414743
[TBL] [Abstract][Full Text] [Related]
40. Mortality Risk of Nonoperative Papillary Thyroid Carcinoma: A Corollary for Active Surveillance.
Ho AS; Luu M; Zalt C; Morris LGT; Chen I; Melany M; Ali N; Patio C; Chen Y; Mallen St-Clair J; Braunstein GD; Sacks WL; Zumsteg ZS
Thyroid; 2019 Oct; 29(10):1409-1417. PubMed ID: 31407637
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
